[HTML][HTML] Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
Background Adagrasib, an oral small-molecule inhibitor of mutant KRAS G12C protein, has
shown clinical activity in pretreated patients with several tumor types, including colorectal …
shown clinical activity in pretreated patients with several tumor types, including colorectal …
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS GC
R Yaeger, J Weiss, MS Pelster, AI Spira, T Kheoh… - marycrowley.org
RESULTS Adagrasib, an oral small-molecule inhibitor of mutant KRAS GC protein, has
shown clinical activity in pretreated patients with several tumor types, including colorectal …
shown clinical activity in pretreated patients with several tumor types, including colorectal …
[引用][C] Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
R Yaeger, J Weiss, MS Pelster, AI Spira… - New England Journal …, 2023 - cir.nii.ac.jp
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated <i>KRAS</i> G12C |
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ …
[HTML][HTML] Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
R Yaeger, J Weiss, MS Pelster, AI Spira… - The New England …, 2023 - ncbi.nlm.nih.gov
BACKGROUND Adagrasib, an oral small-molecule inhibitor of mutant KRAS G12C protein,
has shown clinical activity in pretreated patients with several tumor types, including …
has shown clinical activity in pretreated patients with several tumor types, including …
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
R Yaeger, J Weiss, MS Pelster… - The New England …, 2023 - mayoclinic.elsevierpure.com
BACKGROUND: Adagrasib, an oral small-molecule inhibitor of mutant KRAS G12C protein,
has shown clinical activity in pretreated patients with several tumor types, including …
has shown clinical activity in pretreated patients with several tumor types, including …
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
R Yaeger, J Weiss, MS Pelster… - … England Journal of …, 2023 - pure.johnshopkins.edu
Background Adagrasib, an oral small-molecule inhibitor of mutant KRAS G12C protein, has
shown clinical activity in pretreated patients with several tumor types, including colorectal …
shown clinical activity in pretreated patients with several tumor types, including colorectal …
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
R Yaeger, J Weiss, MS Pelster, AI Spira… - The New England …, 2022 - europepmc.org
Background Adagrasib, an oral small-molecule inhibitor of mutant KRAS G12C protein, has
shown clinical activity in pretreated patients with several tumor types, including colorectal …
shown clinical activity in pretreated patients with several tumor types, including colorectal …
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS GC
R Yaeger, J Weiss, MS Pelster, AI Spira, T Kheoh… - mary-crowley-web.s3.amazonaws …
RESULTS Adagrasib, an oral small-molecule inhibitor of mutant KRAS GC protein, has
shown clinical activity in pretreated patients with several tumor types, including colorectal …
shown clinical activity in pretreated patients with several tumor types, including colorectal …
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C
R Yaeger, J Weiss, MS Pelster… - The New England …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Adagrasib, an oral small-molecule inhibitor of mutant KRAS G12C protein, has
shown clinical activity in pretreated patients with several tumor types, including colorectal …
shown clinical activity in pretreated patients with several tumor types, including colorectal …
Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C.
R Yaeger, J Weiss, MS Pelster, AI Spira… - The New England …, 2022 - europepmc.org
Adagrasib, an oral small-molecule inhibitor of mutant KRAS G12C protein, has shown
clinical activity in pretreated patients with several tumor types, including colorectal cancer …
clinical activity in pretreated patients with several tumor types, including colorectal cancer …